Product
AR-12286
1 clinical trial
2 indications
Indication
ocular hypertensionIndication
Open-angle GlaucomaClinical trial
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 MonthsStatus: Completed, Estimated PCD: 2013-04-01